Decreases in cortisol variability between treated and untreated jaw pain patients

Richard C. Robinson, John P. Garofalo, Robert J. Gatchel

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The study evaluated the impact of treatment on cortisol levels in acute pain patients at high risk for chronic jaw-related pain. Twenty-five patients with jaw pain or facial discomfort (< 6 months) participated in the study. Patients at high risk for chronic pain received biobehavioral intervention, and those at lower risk received standard care. Cortisol levels increased over time in both conditions, F(1, 429) = 6.614, p =.010; however, cortisol variability decreased among those receiving biobehavioral treatment (p <.043), whereas variability increased among those receiving standard treatment. Together, these findings underscore the potential role of cortisol activity in that it may influence the transition from acute pain to chronic pain.

Original languageEnglish (US)
Pages (from-to)179-188
Number of pages10
JournalJournal of Applied Biobehavioral Research
Volume11
Issue number3-4
DOIs
StatePublished - 2006

Fingerprint

Jaw
Hydrocortisone
pain
Pain
Acute Pain
Chronic Pain
Facial Pain
Therapeutics

ASJC Scopus subject areas

  • Social Sciences (miscellaneous)

Cite this

Decreases in cortisol variability between treated and untreated jaw pain patients. / Robinson, Richard C.; Garofalo, John P.; Gatchel, Robert J.

In: Journal of Applied Biobehavioral Research, Vol. 11, No. 3-4, 2006, p. 179-188.

Research output: Contribution to journalArticle

@article{8983f55fcbf445daa0bc6e2717a3bdc4,
title = "Decreases in cortisol variability between treated and untreated jaw pain patients",
abstract = "The study evaluated the impact of treatment on cortisol levels in acute pain patients at high risk for chronic jaw-related pain. Twenty-five patients with jaw pain or facial discomfort (< 6 months) participated in the study. Patients at high risk for chronic pain received biobehavioral intervention, and those at lower risk received standard care. Cortisol levels increased over time in both conditions, F(1, 429) = 6.614, p =.010; however, cortisol variability decreased among those receiving biobehavioral treatment (p <.043), whereas variability increased among those receiving standard treatment. Together, these findings underscore the potential role of cortisol activity in that it may influence the transition from acute pain to chronic pain.",
author = "Robinson, {Richard C.} and Garofalo, {John P.} and Gatchel, {Robert J.}",
year = "2006",
doi = "10.1111/j.1751-9861.2007.00004.x",
language = "English (US)",
volume = "11",
pages = "179--188",
journal = "Journal of Applied Biobehavioral Research",
issn = "1071-2089",
publisher = "Bellwether Publishing, Ltd.",
number = "3-4",

}

TY - JOUR

T1 - Decreases in cortisol variability between treated and untreated jaw pain patients

AU - Robinson, Richard C.

AU - Garofalo, John P.

AU - Gatchel, Robert J.

PY - 2006

Y1 - 2006

N2 - The study evaluated the impact of treatment on cortisol levels in acute pain patients at high risk for chronic jaw-related pain. Twenty-five patients with jaw pain or facial discomfort (< 6 months) participated in the study. Patients at high risk for chronic pain received biobehavioral intervention, and those at lower risk received standard care. Cortisol levels increased over time in both conditions, F(1, 429) = 6.614, p =.010; however, cortisol variability decreased among those receiving biobehavioral treatment (p <.043), whereas variability increased among those receiving standard treatment. Together, these findings underscore the potential role of cortisol activity in that it may influence the transition from acute pain to chronic pain.

AB - The study evaluated the impact of treatment on cortisol levels in acute pain patients at high risk for chronic jaw-related pain. Twenty-five patients with jaw pain or facial discomfort (< 6 months) participated in the study. Patients at high risk for chronic pain received biobehavioral intervention, and those at lower risk received standard care. Cortisol levels increased over time in both conditions, F(1, 429) = 6.614, p =.010; however, cortisol variability decreased among those receiving biobehavioral treatment (p <.043), whereas variability increased among those receiving standard treatment. Together, these findings underscore the potential role of cortisol activity in that it may influence the transition from acute pain to chronic pain.

UR - http://www.scopus.com/inward/record.url?scp=34548803780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548803780&partnerID=8YFLogxK

U2 - 10.1111/j.1751-9861.2007.00004.x

DO - 10.1111/j.1751-9861.2007.00004.x

M3 - Article

AN - SCOPUS:34548803780

VL - 11

SP - 179

EP - 188

JO - Journal of Applied Biobehavioral Research

JF - Journal of Applied Biobehavioral Research

SN - 1071-2089

IS - 3-4

ER -